Dr. Kendall Lisa Hanft, MD

Dr. Hanft practices at South Florida ENT Associates, Inc. in Miami Lakes, Florida.

Dr. Hanft's NPI, 1487654174, was assigned on July 26, 2005. Dr. Hanft graduated from University of Miami, Miller School of Medicine in 1988. Dr. Hanft holds Florida license ME63453.

Dr. Hanft's primary practice is South Florida ENT Associates, Inc., at 15280 Nw 79th Ct, Miami Lakes, FL 33016 in Miami-Dade County. The practice phone is (305) 558-3724.

Dr. Hanft's primary practice is South Florida ENT Associates, Inc. in Miami Lakes, Florida. Dr. Hanft is also affiliated with Boca Raton Regional Hospital. The medical group on file is South Florida ENT Associates. Dmand AI also links Dr. Hanft to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hanft practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Hanft's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Hanft is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Hanft's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Hanft treats.

CMS data shows 4,755 Medicare services from Dr. Hanft across 14 procedure codes in 2024, for 813 Medicare patients. Medicare paid $245,287 for them. Every service was in an office.

CMS counts 813 Medicare patients who saw Dr. Hanft in 2024. The largest group is 75 to 84, with 329 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hanft's median patient age at 65, with 56% women.

In 2024, Dr. Hanft wrote 2,242 Medicare Part D claims for 809 patients. 97% of them were for generic drugs. CMS names the drug for 2,157 of them, across 20 drugs with 11 or more claims each, at $35,998 in total drug cost. In 2023, CMS named 2,270 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hanft for performance year 2024, reported individually. Dr. Hanft accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Hanft. The most frequent topics are Parotid Gland and Parotid Neoplasms. Dr. Hanft's most frequent co-authors are Frank C. Astor, MD and Joseph Haddad, MD.

CMS Open Payments shows 44 general payments to Dr. Hanft from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Optinose US, Inc. paid the most, $452.

Dmand AI lists 5 awards for Dr. Hanft, most recently CMS Stage 1 EHR in 2013.

Dr. Hanft graduated from University of Miami, Miller School of Medicine in 1988.

Dr. Hanft is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.